Loblaw Companies Limited (TSE:L – Get Free Report) has earned an average rating of “Moderate Buy” from the eight analysts that are currently covering the company, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is C$199.25.
Several research analysts have issued reports on L shares. BMO Capital Markets raised their price target on shares of Loblaw Companies from C$220.00 to C$230.00 and gave the stock a “market perform” rating in a report on Friday, July 25th. Royal Bank Of Canada boosted their price objective on Loblaw Companies from C$234.00 to C$267.00 in a report on Monday, July 21st. TD Securities boosted their price objective on Loblaw Companies from C$245.00 to C$250.00 and gave the company a “buy” rating in a report on Friday, July 25th. National Bankshares dropped their target price on Loblaw Companies from C$242.00 to C$60.00 in a report on Wednesday, August 20th. Finally, Scotiabank raised their target price on Loblaw Companies from C$61.00 to C$65.00 and gave the company an “outperform” rating in a report on Thursday, August 21st.
Loblaw Companies Trading Up 0.7%
Loblaw Companies Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Wednesday, October 1st. Stockholders of record on Wednesday, October 1st were issued a $0.5643 dividend. This represents a $2.26 dividend on an annualized basis and a dividend yield of 3.9%. The ex-dividend date was Monday, September 15th. Loblaw Companies’s dividend payout ratio (DPR) is currently 26.06%.
Loblaw Companies Company Profile
Loblaw is one of Canada’s largest grocery, pharmacy, and general merchandise retailers, operating the most expansive store footprint in Ontario and maintaining sizable presences in provinces like Quebec and British Columbia. Key grocery banners include Loblaw, No Frills, and Maxi, while its pharmaceutical operations are the product of its 2014 acquisition of Shoppers Drug Mart.
Featured Stories
- Five stocks we like better than Loblaw Companies
- What Does Downgrade Mean in Investing?
- Palantir’s New Healthcare Deal Boosts AI and Data Reach
- How to Most Effectively Use the MarketBeat Earnings Screener
- GM’s Billion-Dollar Bruise: GM’s Strategic Pivot Makes It a Buy
- 3 Defense Stocks Set to Benefit From Increased Military Spending
- Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead
Receive News & Ratings for Loblaw Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Loblaw Companies and related companies with MarketBeat.com's FREE daily email newsletter.